Covered recipient · General Payments record
DANIELLE M STEVENSON
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2023–2024
$2,186.55
- Reported across 63 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,703.78 | 43 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| GENZYME CORPORATION | $196.22 | 2 |
| Merck Sharp & Dohme Corporation | $146.24 | 3 |
| GlaxoSmithKline, LLC. | $145.92 | 2 |
| Acerta Pharma LLC | $145.90 | 2 |
| Daiichi Sankyo Inc. | $139.44 | 3 |
| EMD Serono, Inc. | $121.71 | 1 |
| Hologic Sales and Service, LLC | $110.21 | 1 |
| E.R. Squibb & Sons, L.L.C. | $103.15 | 1 |
| Genmab U.S., Inc. | $94.82 | 1 |
| PFIZER INC. | $54.93 | 3 |
| Janssen Biotech, Inc. | $51.01 | 3 |
| Astellas Pharma US Inc | $38.66 | 2 |
| EISAI INC. | $38.14 | 2 |
| Alexion Pharmaceuticals, Inc. | $30.45 | 2 |
| Takeda Pharmaceuticals U.S.A., Inc. | $25.38 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $21.61 | 1 |
| Lilly USA, LLC | $21.59 | 1 |
| SOBI, INC | $21.27 | 1 |
| Regeneron Healthcare Solutions, Inc. | $20.12 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $19.52 | 1 |
| Geron Corporation | $19.15 | 1 |
| Celgene Corporation | $18.97 | 1 |
| Ipsen Biopharmaceuticals, Inc | $18.77 | 1 |
| Stemline Therapeutics Inc. | $18.65 | 1 |
| SERVIER PHARMACEUTICALS LLC | $18.28 | 1 |
| Incyte Corporation | $18.06 | 1 |
| ABBVIE INC. | $15.80 | 1 |
| Acrotech Biopharma Inc. | $15.13 | 1 |
| ADC Therapeutics America, Inc. | $14.68 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (43)
Sorted by paying entity, then date · as published by CMS
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2023, 2024
- Source files
- Dataset page · Bulk file · PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.